Gour Medical S.A. (MLGML.PA)

PAR Healthcare Drug Manufacturers - Specialty & Generic

Gour Medical S.A. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Paris, FR. The stock last traded at $0.04, down 20.00% on the session, giving a market capitalisation of $536,272. Its beta of -0.24 implies it has historically moved less than the broad market.

Gour Medical SA specializes in creating and selling a variety of veterinary products designed for companion animals. Its portfolio notably includes cannabidiol (CBD) formulations for pets, which are marketed under the WEEDLEY brand. The company, headquartered in Paris, France, was established in 2014.

Gour Medical S.A. is most often compared with the following Healthcare names: